Clinical Trial Update: Development of a New Non-radioactive Test for Measuring Glomerular Filtration Rate Using the Tetrapeptide N-acetyl-Ser-Asp-Lys-Pro-amide (AcSDKP-NH2) [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating a non-radioactive test for measuring glomerular filtration rate using AcSDKP-NH2 has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• AcSDKP-NH2 (N-acetyl-Ser-Asp-Lys-Pro-amide)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Healthy, Chronic Kidney Disease | Phase 1, Phase 2 | Status: COMPLETED